K. Jarnagin
发表
M. Fielden,
B. P. Eynon,
G. Natsoulis,
2005,
Toxicologic pathology.
M. Fielden,
B. P. Eynon,
G. Natsoulis,
2005,
Journal of biotechnology.
M. Fielden,
G. Natsoulis,
K. Jarnagin,
2008,
Molecular systems biology.
James C. Fuscoe,
Yudong D. He,
Eric Blomme,
2005,
Nucleic acids research.
Frank Diehl,
K. Jarnagin,
R. Wilhelm,
2000,
The Journal of Biological Chemistry.
K. Jarnagin,
U. Förstermann,
C. Figueroa,
2001,
Hypertension.
M. Haasemann,
K. Jarnagin,
W. Müller-Esterl,
1996,
The Journal of Biological Chemistry.
K. Jarnagin,
H. Chan,
B. Nguyen,
1993,
Journal of biotechnology.
K. Jarnagin,
H. Weinberg,
V. Riccardi,
2018,
Neurology.
K. Jarnagin,
A. Hoerauf,
J. McKerrow,
2019,
ACS infectious diseases.
K. Jarnagin,
J. Fausnaugh,
H. Chan,
1991,
Journal of neurochemistry.
Inhibition of Toll-Like Receptor-Mediated Inflammation In Vitro and In Vivo by a Novel Benzoxaborole
K. Jarnagin,
A. Gertrudes,
T. Akama,
2013,
The Journal of Pharmacology and Experimental Therapeutics.
K. Jarnagin,
M. Orr,
J. Plattner,
2013,
Bioorganic & medicinal chemistry letters.
K. Jarnagin,
B. Nare,
R. Brun,
2010,
Antimicrobial Agents and Chemotherapy.
K. Jarnagin,
D. Morgan,
R. Roth,
1986,
Biochemistry.
K. Jarnagin,
S. Hemmerich,
T. Handel,
1999,
Biochemistry.
Structure-based design of six novel classes of nonpeptide antagonists of the bradykinin B2 receptor.
K. Jarnagin,
C. Brotherton-Pleiss,
S. Bhakta,
2000,
Bioorganic & medicinal chemistry letters.
K. Jarnagin,
W. Müller-Esterl,
U. Quitterer,
1996,
Biochemistry.
K. Jarnagin,
H. DeLuca,
S. Yamada,
1983,
The American journal of physiology.
K. Jarnagin,
R. Alvarez,
E. Shelton,
1993,
Gene.
K. Jarnagin,
S. Tugendreich,
Ajay Jain,
2001
.
M. Haasemann,
K. Jarnagin,
C. Figueroa,
1995,
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
K. Jarnagin,
S. Bhakta,
J. Krstenansky,
1995,
Letters in Peptide Science.
K. Jarnagin,
D. Nelson,
L. Spelman,
2016,
Immunotherapy.
K. Jarnagin,
H. DeLuca,
M. Kessler,
1986,
Archives of biochemistry and biophysics.
K. Jarnagin,
S. Bhakta,
J. Krstenansky,
1997
.
K. Jarnagin,
W. Müller-Esterl,
U. Quitterer,
1996,
The Journal of Biological Chemistry.
K. Jarnagin,
V. Gantz,
D. Cowley,
2022,
bioRxiv.
K. Jarnagin,
H. DeLuca,
S. Yamada,
1983,
The American journal of physiology.
K. Jarnagin,
H. DeLuca,
R. Brommage,
1984,
The American journal of physiology.
K. Jarnagin,
S. Hemmerich,
T. Handel,
1999,
Biochemistry.
K. Jarnagin,
S. Hemmerich,
T. Handel,
1998,
The Journal of Biological Chemistry.
K. Jarnagin,
B. Korf,
B. Widemann,
2018,
Neurology.
The human insulin receptor cDNA: The structural basis for hormone-activated transmembrane signalling
K. Jarnagin,
W. Rutter,
Y. Kan,
1985,
Cell.
K. Jarnagin,
R. Aldrich,
E. Shelton,
1991,
Proceedings of the National Academy of Sciences of the United States of America.
Inhibition of Toll-Like Receptor-Mediated Inflammation in vitro and in vivo by a Novel Benzoxaborole
K. Jarnagin,
A. Gertrudes,
T. Akama,
2012
.
K. Jarnagin,
V. Gantz,
D. Cowley,
2023,
bioRxiv.
K. Jarnagin,
F. Rock,
Yong-Kang Zhang,
2013,
The Journal of Pharmacology and Experimental Therapeutics.
R. Abagyan,
K. Jarnagin,
G. A. Lemieux,
2017,
PLoS neglected tropical diseases.
K. Jarnagin,
E. Shelton,
P. Baecker,
2007,
Cell Biochemistry and Biophysics.
K. Jarnagin,
R. Alvarez,
E. Shelton,
1998,
Cellular signalling.
K. Jarnagin,
D. V. Daniels,
E. Shelton,
1997,
Biochimica et biophysica acta.
K. Jarnagin,
D. Webb,
S. Shresta,
2021,
Biochemical Pharmacology.
K. Jarnagin,
V. Ciaravino,
T. Akama,
2012,
Journal of pharmaceutical and biomedical analysis.
P S Pine,
M Boedigheimer,
B A Rosenzweig,
2008,
Pharmacogenomics.
K Jarnagin,
K. Jarnagin,
S. Tugendreich,
2001,
Cancer research.
M. Lebwohl,
K. Jarnagin,
V. Ciaravino,
2016,
Journal of drugs in dermatology : JDD.
K. Jarnagin,
J. Nieman,
Rajeshwar Singh,
2013,
Bioorganic & medicinal chemistry letters.
K. Jarnagin,
J. Nieman,
K. R. Maples,
2012,
FEBS letters.
K. Jarnagin,
K. Kolaja,
S. Tugendreich,
2006,
Toxicologic pathology.
Classification of a large microarray data set: algorithm comparison and analysis of drug signatures.
Gert R. G. Lanckriet,
Stuart Tugendreich,
G. Lanckriet,
2005,
Genome research.
K. Jarnagin,
Olga Zemska,
M. Meewan,
2016,
The Journal of Pharmacology and Experimental Therapeutics.
K. Jarnagin,
S. Bhakta,
Aaron B. Miller,
1996,
Journal of Biological Chemistry.
K. Jarnagin,
D. Swinney,
O. So,
1995,
Gene.
K. Jarnagin,
D. Pearse,
2010,
Current opinion in investigational drugs.
M. Haasemann,
K. Jarnagin,
C. Figueroa,
1994,
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
K. Jarnagin,
H. DeLuca,
A. Parfitt,
1984,
The Journal of clinical investigation.
K. Jarnagin,
2004
.
K. Jarnagin,
H. DeLuca,
M. Phelps,
1985,
Journal of Biological Chemistry.
Leslie J. Browne,
G. Natsoulis,
K. Jarnagin,
2002
.
K. Jarnagin,
D. Cowley,
C. M. Conner,
2023,
Biochemical Pharmacology.
K. Jarnagin,
J. Nieman,
K. R. Maples,
2012,
FEBS letters.
K. Jarnagin,
C. Bach,
W. Müller-Esterl,
1994,
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
R. Abagyan,
K. Jarnagin,
G. A. Lemieux,
2017,
PLoS neglected tropical diseases.
chemical and functional characterization of cyclic 4 (PDE4) as a potential anthelmintic drug target.
K. Jarnagin,
G. A. Lemieux,
Kaveh Ashrafi,
2017
.